About Tivic Health

COMPANY

About Tivic Health

Headquarters: San Francisco Bay Area, CA
Sector: Healthtech, Bioelectronic Medicine
Stage: Commercial

Tivic is a commercial health tech company advancing the field of bioelectronic medicine. Tivic’s patented technology platform leverages stimulation on the trigeminal, sympathetic, and vagus nerve structures.

Tivic’s non-invasive and targeted approach to the treatment of inflammatory chronic health conditions gives consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications.

Tivic’s first commercial product ClearUP is an FDA approved, award-winning, handheld bioelectronic sinus device. ClearUP is clinically proven, doctor recommended, and is available through online retailers and commercial distributors.

McKinsey & Company estimates that bioelectronic medicine “represents a multibillion dollar opportunity even with modest penetration.”

Users and doctors share their experiences with ClearUP

Key Milestones

2016 Q3: Tivic Health was founded
2018 Q2: Completed FDA pivotal trial for ClearUP
2018 Q3: Received FDA 510(k) for ClearUP
2019 Q1: Received FDA’s first clearance for ClearUP
2019 Q3: ClearUP began commercial shipment
2019 Q4: Received ISO 13485 certification
2020 Q1: ClearUP received CE Mark approval
2020 Q3: USPTO granted Tivic’s first patents
2021 Q1: Received FDA’s second clearance for ClearUP
2021 Q2: Over 20,000 lives touched by ClearUP
2021 Q2: Bridge financing closed bringing investment to date $13 million
2021 Q3: Tivic Health set terms for a $17 million IPO
2021 Q4: Tivic Health (“TIVC”) listed on NASDAQ in November
2022 Q1: ClearUP named best sinus pain relief by Global Health & Pharma Magazine
2022 Q2: Broaden our IP portfolio claims to 96 and initiated the development of a product candidate in migraine
2022 Q3: Over 35,000 lives touched by ClearUP
2022 Q4: Reduced 40% in cost for ClearUP from initial product